Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Albany Molecular Research Inc v Arrow Pharmaceuticals Pty Ltd [2011] FCA 252 Citation: Albany Molecular Research Inc v Arrow Pharmaceuticals Pty Ltd [2011] FCA 252
Parties: ALBANY MOLECULAR RESEARCH, INC v ARROW PHARMACEUTICALS PTY LTD (ACN 003 144 170), SIGMA PHARMACEUTICALS LIMITED (ACN 088 417 403), SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594), SIGMA COMPANY LIMITED (ACN 004 132 923) and AVENTIS PHARMACEUTICALS, INC
File number: VID 883 of 2007
Judge: JESSUP J
Date of judgment: 23 March 2011
Legislation: Patents Act 1990 (Cth) s 138
Cases cited: Albany Molecular Research Inc v Alphapharm Pty Ltd [2011] FCA 120
Date of last submissions: 11 March 2011
Place: Melbourne
Division: GENERAL DIVISION
Category: No Catchwords
Number of paragraphs: 6
Counsel for the Applicant: Mr A Archibald QC with Mr A Ryan SC and Ms K Beattie
Solicitor for the Applicant: Phillips Ormonde Fitzpatrick
Counsel for the Respondents: Mr D Shavin QC wth Ms H Rofe
Solicitor for the Respondents: Corrs Chambers Westgarth
IN THE FEDERAL COURT OF AUSTRALIA VICTORIA DISTRICT REGISTRY GENERAL DIVISION VID883 of 2007
BETWEEN: ALBANY MOLECULAR RESEARCH INC
Applicant/First Cross-Respondent
AVENTIS PHARMACEUTICALS, INC
Second Cross-Respondent
AND: ARROW PHARMACEUTICALS PTY LTD (ACN 003 144 170)
First Respondent/First Cross-Claimant
SIGMA PHARMACEUTICALS LIMITED (ACN 088 417 403)
Third Respondent/Third Cross-Claimant
SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate